A new therapeutic modality involving acridine orange excitation by photon energy used during reduction surgery for rhabdomyosarcomas

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 89-94

  Matsubara, Takao ^a   Kusuzaki, Katsuyuki ^a,b   Matsumine, Akihiko ^a   Murata, Hiraoaki ^c   Satonaka, Haruhiko ^a   Shintani, Ken ^a   Nakamura, Tomoki ^a   Hosoi, Hajime ^c   Iehara, Tomoko ^c   Sugimoto, Toru ^c   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Orthopaedic Surgery   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Acridine orange; Limb salvage; Photodynamic therapy; Rhabdomyosarcoma

Indexed keywords

ACRIDINE ORANGE;

ADOLESCENT; ARTICLE; BONE TISSUE; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFANT; LIMB MOVEMENT; MALE; PHOTODYNAMIC SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIODYNAMIC THERAPY; RADIOTHERAPY; RHABDOMYOSARCOMA; SOFT TISSUE CANCER; SURGERY; SURGICAL APPROACH; CASE REPORT; CLINICAL TRIAL; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PHOTON; PRESCHOOL CHILD; SOFT TISSUE TUMOR; TUMOR CELL LINE;

ACRIDINE ORANGE; ADOLESCENT; CELL LINE, TUMOR; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PHOTOCHEMOTHERAPY; PHOTONS; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS;

EID: 61449322893     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000193     Document Type: Article

References (19)

1. Weiss SW and Goldblum JR: Enzinger and Weiss's Soft Tissue Tumors. Fourth edition, Mosby, St. Louis, 2001.
2. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN and Crist WM: Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78-84, 2003.
3. Maurer HM, Beltangady M, Gehan EA, Crist WM, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W and Ortega J: The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61: 209-220, 1988.
4. Crist WM, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J and Heyn R: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610-630, 1995.
5. Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, Wiener ES, Maurer HM and Crist WM: Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23: 215-220, 2001.
6. Mameghan H, Fisher R, Tobias V, Kern IB, O'Gorman-Hughes D, Vowels M and Mameghan J: Local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma: prognostic factors and implications for curative therapy. Med Pediatr Oncol 21: 88-95, 1993.
7. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Ashihara T and Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91: 439-445, 2000.
8. Kusuzaki K, Aomori K, Suginoshita T, Minami G, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas by photodynamic reaction with acridine orange. Oncology 59: 174-180, 2000.
9. Kusuzaki K, Suginoshita T, Minami G, Aomori K, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Fluorovisualization effect of acridine orange on mouse osteosarcoma. Anticancer Res 20: 3019-3024, 2000.
10. Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T and Hirasawa Y: Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology 62: 85-93, 2000.
11. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM and Crist WM: Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 6: 550-561, 1998.
12. Enneking WF, Dunham W, Gebhardt MC, Malawar M and Prichard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 286: 241-246, 1993.
13. Kusuzaki K, Murata H, Takeshita H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T and Hirasawa Y: Intracellular binding sites of acridine orange in living osteosarcoma cells. Anticancer Res 20: 971-976, 2000.
14. Matsubara T, Kusuzaki K, Matsumine A, Shintani K, Satonaka H and Uchida A: Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. Anticancer Res 26: 187-193, 2006.
15. Satonaka H, Kusuzaki K, Matsubara T, Shintani K, Wakabayashi T, Matsumine A and Uchida A: Extracorporeal photodynamic image detection of mouse osteosarcoma in soft tissues utilizing fluorovisualization effect of acridine orange. Oncology 70: 465-473, 2006.
16. Kusuzaki K, Murata H, Matsubara T, Satonaka H, Wakabayashi T, Matsumine A and Uchida A: Acridine orange could be an innovative anticancer agent under photon energy. In Vivo 21: 205-214, 2007.
17. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 25: 1225-1235, 2005.
18. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Shintani K, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas. Photochem Photobiol 81: 705-709, 2005.
19. Yoshida K, Kusuzaki K, Matsubara T, Matsumine A, Kumamoto T, Komada Y, Naka N and Uchida A: Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange. Oncol Rep 13: 279-282, 2005.